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Abstract: Stress responses during cocaine withdrawal likely contribute to 
drug relapse and may be intensified as a consequence of prior cocaine use. 
The present study examined changes in stressor‐induced activation of the 
hypothalamic‐pituitary‐adrenal (HPA) axis during acute withdrawal from 
chronic cocaine administration. Adult male Sprague Dawley rats received daily 
administration of cocaine (30 mg/kg, IP) or saline for 14 days. Twenty‐four 
hours after the last injection, rats in each group were sacrificed under stress‐
free conditions or following 30 minutes of immobilization. Plasma 
corticosterone (CORT) was measured in trunk‐blood using radioimmunoassay, 
corticotropin‐releasing hormone (CRH) mRNA levels in the paraventricular 
nucleus (PVN) of the hypothalamus were measured using in situ hybridization 
and glucocorticoid receptor (GR) protein expression in the pituitary gland and 
dissected brain regions was measured using Western blot analysis. Basal CRH 
mRNA in the PVN was unaltered as a result of prior cocaine administration. 
However, a significant increase in CRH mRNA was observed 90 minutes 
following the termination of restraint in cocaine withdrawn, but not 
salinetreated, rats. Basal CORT was also unaffected by prior cocaine 
administration, but the CORT response measured immediately after restraint 
was significantly augmented in cocaine‐withdrawn rats. Differences in GR 
protein expression in number of regions implicated in negative feedback 
regulation of HPA function, including the hypothalamus, were not observed. 
These findings indicate that the HPA response to stressors is intensified during 
early withdrawal from cocaine administration and may be independent of 
changes in GR‐mediated negative feedback. 
Keywords: Cocaine, stress, glucocorticoid receptor, CRF, HPA axis, 
corticosterone 
Introduction 
A growing body of evidence suggests that stress plays an 
important role in cocaine addiction [11, 28]. In addition to findings 
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that stress promotes cocaine‐seeking behavior, it has been reported 
that stress‐related behavioral responses emerge and/or are 
exaggerated as a consequence of prior cocaine exposure, suggesting 
that the relationship between stress and cocaine abuse represents a 
self‐perpetuating cycle within which stress serves as both a 
precipitating factor for and a consequence of drug use. 
The hypothalamic pituitary adrenal (HPA) axis is a critical 
mediator of physiological responses that enable organisms to adapt 
during times of stress. Such responses likely include changes in 
behavior that involve the same neurocircuitry responsible for illicit 
drug use and addiction. Accordingly, it has been reported that 
although stressor‐induced glucocorticoid secretion is not necessary for 
acute stressor‐induced cocaine‐seeking behavior [9], glucocorticoids 
play an important role in the effects of repeated stress on the 
addiction process as substrates through which chronic stressors 
increase cocaine self‐administration [20] and facilitators of addiction‐
related neuroplasticity [19]. 
Like stressors, cocaine stimulates the HPA axis through a 
mechanism dependent on the release of the peptide corticotropin 
releasing hormone (CRH) from the terminals of parvocellular neurons 
originating in the paraventricular nucleus (PVN) of the hypothalamus 
[23, 24]. Repeated cocaine administration has been reported to 
produce long‐term alterations in basal HPA function [18, 26, 30, 32] 
that can also be observed in human addicts as a dysregulation of 
circadian HPA activity [7]. Less is known about how stressor‐induced 
HPA activation is altered as a consequence of prior cocaine use. 
Although there are reports that restraint‐induced corticosterone 
(CORT) secretion is unchanged following repeated psychomotor 
stimulant drug administration [17], others have found that HPA 
responses to stressors [2] and cocaine [27] are augmented, while still 
others have reported that individual differences in stressor‐induced 
CORT are eliminated following chronic cocaine administration, with the 
CORT response increasing in rats that were initially low CORT 
responders and decreasing in high responder rats [26]. 
Clinical studies have found that the HPA response to stressors is 
augmented in recovering cocaine abusers with a history of high 
frequency drug use [10] and that stressor‐induced cortisol and ACTH 
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responses predict propensity towards drug relapse [29]. Thus, 
intensification of stressor‐induced HPA function following chronic 
cocaine administration could contribute to the addiction process by 
promoting further drug use. 
The goal of this study was to examine the activity of the HPA 
axis under basal conditions and in response to a stressor, restraint, 
after 24 hours of withdrawal from 14 days of cocaine administration 
(30 mg/kg, IP daily). HPA function was assessed through 
determination of plasma CORT concentrations and CRH mRNA levels in 
the PVN measured using in situ hybridization. Additionally, since 
glucocorticoid receptors (GR) are known to play an inhibitor feedback 
role in HPA function [8], we also examined GR expression in pituitary 
and a number of brain regions using Western blot analysis. 
Methods 
Subjects 
Forty‐eight adult male Sprague‐Dawley rats (Harlan 
Laboratories, St. Louis, MO), approximately 90 days old were housed 
in pairs in a temperature‐ and humidity‐controlled, AAALAC‐accredited 
facility under a 12h/12h light/dark cycle (lights on at 7:00 am) and 
had access to food and water at all times. Experiments were conducted 
in accordance with the NIH Guide for the Care and Use of Laboratory 
Animals (Publication No. 80‐23; rev. 1996). 
Cocaine/Saline Injection Regimen 
After a one‐week habituation period during which they received 
daily saline injections, rats were assigned to cocaine or saline 
treatment groups according to the ip injection regimen that they 
received for the next 14 days. Cocaine rats received daily ip injections 
of cocaine (30 mg/kg; NIDA Drug Supply Program) while saline rats 
received injections of 0.9% NaCl solution. Rats received injections at 
10:00 AM. 
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Immobilization Stress and Sacrifice 
All rats were sacrificed 24 hours after the final injection (at 10 
AM) by decapitation under one of three conditions: 1) immediately 
after removal from the homecage for baseline CORT and CRH mRNA 
measurement; 2) immediately following 30 minutes of restraint for 
measurement of stressor‐induced increases in plasma CORT and 
regional glucocorticoid receptor (GR) protein expression; and 3) ninety 
minutes after the termination of restraint for measurement of stressor‐
induced CRH mRNA expression and recovery of CORT levels following 
stress. During the 90‐min period prior to sacrifice, rats in this group 
were returned to their home cages. Restraint stress consisted of a 30‐
min period during which rats were placed into acrylic restraining 
devices (21.6 cm length × 6.4 cm diameter). Following decapitation, 
trunk blood was collected for plasma CORT measurement and brain 
was rapidly excised and frozen in a −30° C isopentane solution. 
Pituitary gland was also removed and frozen on dry ice. Brain and 
pituitary were transferred to a −80° C freezer for storage. 
Measurement of Plasma CORT 
Plasma CORT was measured using a commercial 
radioimmunoassay kit (MP Biochemicals, Irvine, CA). Blood for CORT 
determination was collected into tubes containing heparin, stored on 
ice, and centrifuged to allow separation of plasma, which was frozen at 
−80° C. 
In Situ Hybridization and Image Analysis 
Analysis of hybridization signal involved sampling across the 
rostral‐caudal extent of the medial parvocellular PVN and 
measurements for individual rats were averaged to obtain one mean 
value. Data from the rostral‐most level of the PVN was excluded due to 
an inadequate number of sections. 35S‐labeled anti‐sense probes for 
CRH were generated from linearized cDNA encoding a 760bp segment 
spanning from exon 2 to the 3’ untranslated region. The specificity of 
this probe has been previously characterized [12]. Linearized DNA 
template was transcribed to anti‐sense riboprobe with T7 polymerase, 
followed by isolation of probe by high salt/ethanol precipitation. Slides 
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with 16 µm cryosectioned coronal brain slices containing the PVN [21] 
were subjected to standard pre‐hybridization treatment (post‐fixation 
in 4% paraformaldehyde; glycine treatment; acetylation; 
dehydration/delipidationin ethanols/chloroform; air‐drying). Probe was 
diluted in commercial hybridization buffer (Amresco Solon, OH) with 
100 mM DTT. Each slide was hybridized with 50µl of medium 
containing 106 cpm probe/50µl), coverslipped, and incubated overnight 
at 55°C in chambers humidified with 50% formamide. Following 
incubation, slides were post‐treated (rinses in 2X SSC; 200 µg/ml 
RNAse digestion of unbound probe; SSC rinses; 55°C hot bath in 0.2X 
SSC; dehydration in ethanols; air drying) and exposed to Kodak 
BioMAX MR autoradiographic film for 1 week. Densitometric analysis 
was performed using Scion Image 1.59 software. Data are presented 
as corrected gray level (gray level of sampled area minus gray level of 
non‐specifically labeled background region (white matter) in the same 
section). 
PAGE Western Blot Analysis 
Frozen brains were thawed on ice to permit dissection of medial 
prefrontal cortex, dorsomedial hypothalamus (including PVN), 
amygdala, dorsal hippocampus, and ventral subiculum. Brains were 
placed into a stainless steel brain block cooled to −20° C and slices 
(1–2 mm) were cut using a straight edge razor blade. Coronal slices 
from which tissues were dissected were defined according to 
coordinates from Paxinos and Watson [21]. Samples were 
homogenized by sonication on ice in a Tris buffer (50 mM Tris, pH 7.2) 
containing 10% (wt/vol) sucrose, 6 mM MgCl2 and protease inhibitors 
(1 mM EDTA, 1 mM PMSF, 3 mM benzamidine, 5 µg/ml leupeptin, 1 
µg/ml pepstatin A, 1 µg/ml aprotinin, 5 µg/ml bestatin, 2 µg/ml E64). 
GR protein was measured in samples of whole cell tissue homogenate 
using polyacrylamide gel electrophoresis [15] followed by Western blot 
analysis with the polyclonal antibody, GR M‐20 (Santa Cruz 
Biotechnology, Santa Cruz, CA). Following protein determination using 
the bicinchoninic acid assay, samples were diluted in buffer (pH = 6.8; 
final concentration 0.25 M Tris‐HCl, 4 M urea, 10% glycerol, 1% SDS, 
5% beta‐mercaptoethanol) and loaded onto a 7.5% polyacrylamide gel 
(30 µg protein/lane). Gel electrophoresis was performed using a Bio‐
Rad Mini‐protean 3 system at 200 V for 20 min followed by 35‐40 min 
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at 180 V. Samples were transferred onto Bio‐Rad Immun‐Blot™ PVDF 
membranes at 100 V for 50 min at 4° C using a Bio‐Rad Mini‐Transblot 
wet transfer system. Following repeated washes and blocking in a TBS 
solution containing 10% non‐fat dried milk and 0.5 µl/ml Tween‐20 
solution for 90 minutes, membranes were incubated with GR M‐20 
(1∶500) for 2 hours at room temperature and subsequently with a 
secondary horseradish peroxidase‐labeled antibody (donkey anti‐
rabbit; Amersham Biosciences; 1∶5000) for 90 min at room 
temperature. An enhanced chemiluminescent detection system 
(Amersham Biosciences) was used to detect immunoreactive bands. 
Optical density readings were determined using a Kodak ImageStation 
4000MM system. Raw optical density data were converted to 
percentages of the mean density for SAL samples on the same 
membrane. 
Statistical Analyses 
The statistical significance of differences between groups was 
examined using 2‐way ANOVA followed by post‐hoc analysis using the 
Fisher’s LSD test. A Bonferroni‐adjusted t‐test following one‐way 
ANOVA was used for planned comparisons. Statistical analyses were 
performed using SPSS 14.0 software. Statistical significance was 
defined as P < 0.05. 
Results 
Plasma CORT 
Figure 1 shows basal and restraint‐induced increases in plasma 
CORT in saline‐ and cocaine‐treated rats. Two‐way restraint condition x 
cocaine treatment group ANOVA examining plasma CORT immediately 
following restraint showed a significant effect of restraint 
(F1,26=117.52; P<0.0001) but not cocaine (P=0.063) and a significant 
restraint x cocaine interaction (F1,26=4.59; P<0.05). Restraint 
significantly increased plasma CORT in both cocaine‐ and saline‐treated 
rats (P<0.0001). However, plasma CORT following restraint was 
significantly higher in cocaine‐treated rats compared to saline controls 
(P<0.05). No differences were observed between groups 90 minutes 
after restraint. 
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Figure 1 Plasma corticosterone (CORT) response to restraint in saline and cocaine 
treated rats. Data represent mean plasma CORT levels (ng/ml ± SE) under basal 
conditions (n=8 per group), immediately following 30 min of immobilization (n=7 per 
group), and after a 90‐min recovery period following immobilization (n=8 per group), 
24 hours into withdrawal from daily cocaine (COC; 14 × 30 mg/kg, ip) or saline (SAL). 
The plasma CORT response to restraint was augmented in COC rats (#P < 0.0001 vs. 
basal; * P<0.05 vs SAL). 
CRH mRNA in the PVN 
CRH mRNA levels under basal conditions and 90 min after 
restraint in saline‐ and cocaine‐treated rats are shown in Figure 2. 
Two‐way restraint condition x cocaine treatment ANOVA examining the 
CRH mRNA in the PVN showed a significant overall effect of restraint 
(F1,23=5.30; P<0.05), but no significant effect of cocaine and no 
significant restraint x cocaine interaction despite a statistically non‐
significant trend (P=0.08). However, a separate planned comparison of 
restraint‐induced increases in CRH mRNA using a Bonferroni corrected 
t‐test showed that restraint significantly increased CRH mRNA in 
cocaine‐treated rats, but not saline controls (P<0.05). 
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Figure 2 Effects of restraint on PVN CRH mRNA levels in cocaine‐ and saline‐treated rats. Data in 
Figure 2A represent the density of CRH mRNA in the medial rostral‐caudal level of the PVN in saline‐ (SAL) 
and cocaine‐ (COC) treated rats determined by in situ hybridization. Density was defined as the corrected 
gray level (gray level of PVN minus gray level of non‐specifically labeled background region (white matter) in 
the same section). A significant restraint‐induced increases in CRH mRNA was found in COC, but not SAL rats 
(*P<0.05 vs. SAL). Images in Figure 2B show representative CRH mRNA expression in the PVN from all 4 
groups. Sal/Basal = saline/non‐stressed; Sal/Res = saline /restraint; Coc/Basal = cocaine/non‐stressed; 
Coc/Res = cocaine/restraint. Each image was digitally captured from films with NIH Image software and 
imported into Adobe Photoshop for assembly, with identical adjustments applied to all. 
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GR protein expression 
Regional differences in GR protein expression between cocaine‐ 
and saline‐treated rats were analyzed using two‐tailed Student’s t‐tests 
and are shown in Table 1. No significant differences were observed in 
any region examined. 
 
DISCUSSION 
The primary findings of the present study are that the 
hypothalamic CRH mRNA and CORT responses to a stressor, 30 min of 
restraint, are augmented during acute (24‐h) withdrawal from chronic 
cocaine administration (14 days of 30 mg/kg, ip). The findings differ 
from earlier reports that 7 days of 15 mg/kg cocaine failed to alter the 
CORT response to 20 minutes of immobilization 42 hours after the final 
injection [17] and reports of no changes in the CORT response to 60 
minutes of immobilization 21 hours after the final injection of a 3‐ or 6‐
week “binge’ cocaine regimen (3 × 15 mg/kg, daily) [26]. In the latter 
study, individual differences were found with increases in 
responsiveness in rats that initially displayed a lower CORT response 
to restraint and reductions in responsiveness in high CORT responders. 
The reasons for the discrepant findings are unclear, but a number of 
factors, including differences in duration of restraint and cocaine 
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treatment, cocaine dose, time of day at which CORT was measured, 
strain of rat, and length of withdrawal, may have contributed. Our 
findings are consistent with reports that the CORT and ACTH responses 
to restraint were augmented in rats that received a 2‐week escalating 
single daily dose regimen of d‐amphetamine when measured 14 days 
into withdrawal [2] and with clinical reports that the HPA response to 
stressors is augmented in recovering cocaine abusers with a history of 
high frequency drug use [10]. Notably, similar discrepancies have 
been found when examining the effects of repeated drug exposure on 
the HPA response to cocaine with no changes in [5, 16], augmentation 
of [27], and attenuation of [30] the response reported, depending on 
the treatment parameters used. 
The present study is, to our knowledge, the first to describe 
restraint‐induced increases in CRH mRNA during acute withdrawal. It is 
likely that the elevation of CRH mRNA in the PVN represents a 
replenishing of parvocellular neurons to compensate for earlier CRH 
peptide release, further suggesting that the restraint‐induced HPA 
response was augmented in cocaine‐treated rats. However, although 
the responses are presumably proportional, the precise relationship 
between the CRH peptide and mRNA responses is not entirely clear. 
Considering that restraint‐induced increases in CRH mRNA in the PVN 
have been previously reported in drug‐naïve rats [14], we were 
surprised at the lack of effect in our saline controls, especially since we 
observed a robust restraint‐induced increase in plasma CORT. Notably, 
very rapid post‐restraint increases in CRH mRNA in the PVN (i.e., less 
than one hour) have been reported [13]. Thus, we may have missed 
the peak CRH mRNA response in our saline rats, implying that chronic 
cocaine may change the duration as well as the magnitude of the CRH 
mRNA response. Alternatively, the repeated handling and saline 
injections in the control group may have dampened the HPA response 
in a manner that was surmountable by prior cocaine exposure. 
Although the responses to restraint were augmented in cocaine‐
treated rats, no differences in basal CORT and CRH mRNA levels in the 
PVN were observed. These findings are consistent with reports that 
hypothalamic CRH mRNA levels measured using a solution 
hydridization RNase protection assay are unchanged on day one of 
withdrawal from chronic “binge” pattern cocaine [31] and with reports 
that basal CORT levels are unaltered [4, 17, 32]. Zorilla et al [32] also 
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reported that hypothalamic CRH‐like immunoreactivity was unaltered 
24 hours into withdrawal. However, others have found that plasma 
CORT and/or ACTH is elevated following repeated cocaine 
administration when measured 21 hrs into withdrawal from either 3 or 
6 weeks of chronic daily “binge‐pattern” (i.e., 3 × 15 mg/kg at 1‐h 
intervals) [26, 31] or 24 hours into withdrawal from one week of twice 
daily 10 mg/kg cocaine [1]. 
We also examined GR expression in the pituitary gland and 
several brain regions implicated in negative feedback regulation of the 
HPA axis and found no differences between cocaine‐ and saline‐
withdrawn rats. Although these findings suggest that the augmented 
HPA response was independent of impaired GR‐mediated feedback 
inhibition, functional measures of feedback (e.g., sensitivity to 
dexamethasone suppression and closer scrutiny of the time‐course of 
the decline in plasma CORT following restraint) are necessary to clarify 
the contribution of altered negative feedback. Further investigation is 
required to determine the role of adaptations within the HPA axis that 
are independent of GR‐mediated feedback in the intensified stress 
response. 
Importantly, this study examined the effects of investigator‐
administered cocaine on the HPA axis. It has been demonstrated that 
the effects of cocaine on the HPA axis differ depending on if the drug is 
self‐administered or delivered in a response non‐contingent manner 
[6]. Determination of alterations in stressor‐responsiveness that are 
relevant to addiction will likely require the use of self‐administration 
protocols that simulate use patterns in human addicts. 
To summarize, we demonstrate that stressor‐induced activation 
of the HPA axis is augmented during acute cocaine withdrawal. Along 
with previous reports that behavioral measures of anxiety [3, 25] and 
CRH activity in the amygdala [22, 32] are also augmented during 
acute withdrawal, our findings suggest that stressor responsiveness is 
intensified as a result of prior cocaine exposure. Considering the role 
of stress as a determinant of cocaine‐seeking behavior, one 
consequence of heightened stressor responsiveness could be a greater 
propensity to engage in further cocaine use. This assertion is 
supported the findings of Sinha et al [29] that stressor‐induced HPA 
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responses predict the likelihood of drug relapse in recovering cocaine‐
dependent subjects. 
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